Wausau Comprehensive Treatment Center is a licensed substance use treatment provider in Wausau, WI, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. On site detox services are available, so withdrawal can be managed before treatment begins. Methadone is available as part of medication assisted treatment for opioid use disorder. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting BadgerCare Plus. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient detoxificationOutpatient day treatment or partial hospitalizationOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentDetoxification
Medications
Methadone used in TreatmentBuprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Opioids detoxificationMedication routinely used during detoxification
Payment accepted
IHS/Tribal/Urban (ITU) fundsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyCommission on Accreditation of Rehabilitation Facilities (CARF)SAMHSA certification for opioid treatment program (OTP)Drug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
111 West Jackson Street, Wisconsin Rapids, WI 54495
OutpatientOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare